Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program

Author:

Gold NicholasORCID,Christensen Rebecca A. G.ORCID,Arneja JasleenORCID,Aminoleslami ArianORCID,Anderson Geoffrey M.ORCID,Brooks Jennifer D.ORCID

Abstract

Abstract Purpose The Ontario Breast Screening Program (OBSP) offers free screening mammograms every 2 years, to women aged 50–74. Study objectives were to determine demographic characteristics associated with the adherence to OBSP and if women screened in the OBSP have a lower stage at diagnosis than non-screened eligible women. Methods We used the Ontario cancer registry (OCR) to identify 48,927 women, aged 51–74 years, diagnosed with breast cancer between 2010 and 2017. These women were assigned as having undergone adherent screening (N = 26,108), non-adherent screening (N = 6546) or not-screened (N = 16,273) in the OBSP. We used multinomial logistic regression to investigate the demographic characteristics associated with screening behaviour, as well as the association between screening status and stage at diagnosis. Results Among women with breast cancer, those living in rural areas (versus the largest urban areas) had a lower odds of not being screened (odds ratio [OR] 0.73, 95% confidence interval [CI] 0.68, 0.78). Women in low-income (versus high-income) communities were more likely not to be screened (OR 1.42, 95% CI 1.33, 1.51). When stratified, the association between income and screening status only held in urban areas. Non-screened women were more likely to be diagnosed with stage II (OR 1.91, 95% CI 1.82, 2.01), III (OR 2.96, 95% CI 2.76, 3.17), or IV (OR 8.96, 95% CI 7.94, 10.12) disease compared to stage I and were less likely to be diagnosed with ductal carcinoma in situ (DCIS) (OR 0.91, 95% CI 0.84–0.98). Conclusions This study suggests that targeting OBSP recruitment efforts to lower income urban communities could increase screening rates. OBSP adherent women were more likely to be diagnosed with earlier stage disease, supporting the value of this initiative and those like it.

Funder

Canadian Institutes for Health Research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference32 articles.

1. (2021) Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada, Canadian Cancer Statistics 2021. Toronto ON: Canadian Cancer Society

2. Ontario Breast Screening Program (OBSP). Cancer care Ontario 2017. https://www.cancercareontario.ca/en/cancer-care-ontario/programs/screening-programs/ontario-breast-obsp. Accessed 10 July 2021

3. Ontario Health (Cancer Care Ontario) (2021) Ontario cancer screening performance report 2020. Toronto: Ontario Health

4. Khil L, Heidrich J, Wellmann I, Kääb-Sanyal V, Weigel S, Heindel W et al (2020) Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study. BMC Cancer 20:174. https://doi.org/10.1186/s12885-020-6646-5

5. de Munck L, Siesling S, Fracheboud J, den Heeten GJ, Broeders MJM, de Bock GH (2020) Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands. Br J Cancer 123:1191–1197. https://doi.org/10.1038/s41416-020-0968-6

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3